These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12208102)

  • 41. Current status of veterinary vaccines.
    Meeusen EN; Walker J; Peters A; Pastoret PP; Jungersen G
    Clin Microbiol Rev; 2007 Jul; 20(3):489-510, table of contents. PubMed ID: 17630337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA immunization--a new chance in vaccine research?
    Henke A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):187-90. PubMed ID: 12458358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA vaccines against enteric infections.
    Herrmann JE
    Vaccine; 2006 May; 24(18):3705-8. PubMed ID: 16095769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA vaccines for biodefence.
    Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant viruses as vaccines against viral diseases.
    Souza AP; Haut L; Reyes-Sandoval A; Pinto AR
    Braz J Med Biol Res; 2005 Apr; 38(4):509-22. PubMed ID: 15962176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleic acid vaccines: veterinary applications.
    Babiuk LA; Lewis PJ; van Drunen Little-van den Hurk S; Tikoo S; Liang X
    Curr Top Microbiol Immunol; 1998; 226():90-106. PubMed ID: 9479838
    [No Abstract]   [Full Text] [Related]  

  • 47. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Cre Recombinase-Mediated In Vivo Minicircle (CRIM) DNA Vaccine Platform for Veterinary Application.
    Jiang Y; Yang G; Wang C
    Methods Mol Biol; 2021; 2197():3-12. PubMed ID: 32827129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral vaccines for bony fish: past, present and future.
    Salgado-Miranda C; Loza-Rubio E; Rojas-Anaya E; García-Espinosa G
    Expert Rev Vaccines; 2013 May; 12(5):567-78. PubMed ID: 23659303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA vaccines: technology and application as anti-parasite and anti-microbial agents.
    Alarcon JB; Waine GW; McManus DP
    Adv Parasitol; 1999; 42():343-410. PubMed ID: 10050276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA vaccines--challenges in delivery.
    Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmid-DNA lipid and polymeric nanovaccines: a new strategic in vaccines development.
    Tejeda-Mansir A; García-Rendón A; Guerrero-Germán P
    Biotechnol Genet Eng Rev; 2019 Apr; 35(1):46-68. PubMed ID: 30587085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent developments in veterinary vaccinology.
    Shams H
    Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of DNA vaccination by different routes of immunisation in sheep.
    De Rose R; Tennent J; McWaters P; Chaplin PJ; Wood PR; Kimpton W; Cahill R; Scheerlinck JP
    Vet Immunol Immunopathol; 2002 Nov; 90(1-2):55-63. PubMed ID: 12406655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Important mammalian veterinary viral immunodiseases and their control.
    Patel JR; Heldens JG; Bakonyi T; Rusvai M
    Vaccine; 2012 Feb; 30(10):1767-81. PubMed ID: 22261411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines.
    van Rooij EM; Moonen-Leusen HW; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vaccine; 2006 Feb; 24(9):1264-73. PubMed ID: 16289276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.
    Scott VL; Patel A; Villarreal DO; Hensley SE; Ragwan E; Yan J; Sardesai NY; Rothwell PJ; Extance JP; Caproni LJ; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1972-82. PubMed ID: 26091432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GALVmed awarded £31 million to scale-up its work on vaccines.
    Vet Rec; 2012 Mar; 170(9):216. PubMed ID: 22391897
    [No Abstract]   [Full Text] [Related]  

  • 59. DNA Vaccine Delivery and Improved Immunogenicity.
    Porter KR; Raviprakash K
    Curr Issues Mol Biol; 2017; 22():129-138. PubMed ID: 27831541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA vaccines.
    Reyes-Sandoval A; Ertl HC
    Curr Mol Med; 2001 May; 1(2):217-43. PubMed ID: 11899073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.